Sparrow Clinton Hospital in St. Johns, Mich., has added wide bore MRI equipment to give patients more room and ease anxiety about undergoing a scan.
Category: ROOT
PeaceHealth reports $82M loss amid expense increase, lower investment return
Vancouver, Wash.-based PeaceHealth reported an increased quarterly loss totaling $82.2 million as expenses rose and investment returns dwindled. That figure, which covers the three months leading up to Sept. 30, marks another sharp downturn for the com…
Patients struggling to find diabetes drug popularized on TikTok, Baptist Health South Florida says
A prescription drug intended to help people with diabetes and help with long-term weight management is experiencing shortages because of its popularization as a weight loss drug on TikTok.
Tower Health cuts staff amid hospital sale, closures
West Reading, Pa.-based Tower Health on Nov. 16 laid off 52 corporate employees as the health system shrinks from six hospitals to four, according to The Philadelphia Inquirer.
6 things to know about USPI, the largest ambulatory network in the U.S.
United Surgical Partners International, the largest ambulatory network in the U.S, currently has partner clinics in 35 states across the U.S. Here are six things to know about USPI:
12 gastroenterology updates
From an acquisition to expanded CMS coverage, here are 12 gastroenterology updates Becker’s has reported on since Nov. 2:
ASCs making strides in Texas
The ASC market in Texas continues to grow, with one orthopedic ASC in the state being ranked the top in the country this year. Here are three updates on the Texas ASC market:
Meritus Health names Miranda Ramsey new VP of physician services
Miranda Ramsey was named vice president of physician services for Hagerstown, Md.-based Meritus Health.
Denver Health, city and county of Denver propose $70M operating agreement
Denver Health, alongside the city and county of Denver, have updated the health system’s $70 million operating agreement with 35 changes to the original document, the Denver Gazette reported Nov. 15.
Humira biosimilars earn spot on OptumRx’s formulary
OptrumRx, UnitedHealth’s pharmacy benefit manager, will keep AbbVie’s best-selling rheumatoid arthritis drug Humira on its formulary in 2023 alongside three competing biosimilar versions set to debut next year, Bloomberg reported Nov. 15.
